Skip to main content

chemotherapy Archives

Correctly copying DNA

Mar. 14, 2019—A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.

Read more


Grant enhances study of new chemotherapy targets

Oct. 18, 2018—Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Read more


Cochran celebrates cancer treatment’s end in style

Oct. 4, 2018—Singer Anita Cochran had famous friends in the room when she celebrated her last cancer treatment, but the person with her who mattered the most was her 89-year-old father.

Read more


A new mode of DNA repair

Apr. 14, 2017—Structural details of a protein that removes DNA lesions shed light on fundamental mechanisms of DNA repair.

Read more


Chemo better option following pancreatic cancer surgery: study

Feb. 25, 2016—A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.

Read more


New lead for ovarian cancer treatment

Dec. 10, 2015—Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer.

Read more


Hach shows age not always a barrier to cancer therapy

Sep. 3, 2015—Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years.

Read more


Study seeks to ease ‘chemobrain’ for cancer patients

Aug. 20, 2015—Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment.

Read more


Drug combos enhance ovarian cancer cell death

Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.

Read more


Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Jun. 25, 2015—Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

Read more


Dietitian and friends donate chemo care bags to VICC patients

May. 28, 2015—A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients.

Read more


Improving breast cancer chemo by testing tumors in a dish

Oct. 28, 2014—A team of biomedical engineers has developed a new "tumor-in-a-dish" technology that promises to improve the effectiveness of chemotherapy.

Read more


Recent Stories from VUMC News and Communications Publications

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Hope

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

Momentum

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

more